{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:37:17Z","timestamp":1770831437459,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1996,3,1]],"date-time":"1996-03-01T00:00:00Z","timestamp":825638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med"],"published-print":{"date-parts":[[1996,3]]},"DOI":"10.1007\/bf00837630","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T14:44:25Z","timestamp":1103553865000},"page":"312-319","source":"Crossref","is-referenced-by-count":115,"title":["Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Frank","family":"Gr\ufffdnwald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schomburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edzard","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bultmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Palmedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\ufffdrgen","family":"Ruhimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\ufffdrgen","family":"Biersack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.1985.tb00186.x","volume":"23","author":"AWG Goolden","year":"1985","unstructured":"Goolden AWG. The indication for ablating normal thyroid tissue with131I in differentiated thyroid cancer.Clin Endocrinol 1985; 23: 81?86.","journal-title":"Clin Endocrinol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1002\/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO;2-W","volume":"71","author":"S Dadparvar","year":"1993","unstructured":"Dadparvar S, Krishna L, Brady LW et al. The role of131iodine-Na and201thallium imaging and serum thyroglobulin in the management of differentiated carcinoma.Cancer 1993; 71: 3767?3773.","journal-title":"Cancer"},{"key":"CR3","first-page":"1393","volume":"33","author":"HR Balone","year":"1992","unstructured":"Balone HR, Fing-Bennett D, Stoffer SS.99mTechnetium-sestamibi uptake by recurrent H\u00fcrthle cell carcinoma of the thyroid.J Nucl Med 1992; 33: 1393?1395","journal-title":"J Nucl Med"},{"key":"CR4","first-page":"249","volume-title":"Handbook of targeted delivery of imaging agents","author":"E Klemm","year":"1995","unstructured":"Klemm E, Hotze AL, Briele B, Biersack HJ.99mTc-MIBI and201thallium scintigraphy in the follow-up of differentiated thyroid carcinoma. In: Hollinger MA, ed.Handbook of targeted delivery of imaging agents. Boca Raton, Fl.: CRC Press; 1995: 249?256."},{"key":"CR5","first-page":"115","volume":"30","author":"B Briele","year":"1991","unstructured":"Briele B, Hotze AL, Kropp J, et al. A comparison of 201Ti and99mTc-MIBI in the follow-up of differentiated thyroid carcinoma.Nucl Med 1991; 30: 115?124.","journal-title":"Nucl Med"},{"key":"CR6","first-page":"623","volume":"32","author":"LG Strauss","year":"1991","unstructured":"Strauss LG, Conti PS. The application of PET in clinical oncology.J Nucl Med 1991; 32: 623?648.","journal-title":"J Nucl Med"},{"key":"CR7","first-page":"1555","volume":"32","author":"RA Hawkins","year":"1991","unstructured":"Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluation with FDG [editorial].J Nucl Med 1991; 32: 1555?1557.","journal-title":"J Nucl Med"},{"key":"CR8","first-page":"910","volume":"28","author":"H Joensuu","year":"1987","unstructured":"Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.J Nucl Med 1987; 28: 910?914.","journal-title":"J Nucl Med"},{"key":"CR9","first-page":"1090","volume":"77","author":"JC Sisson","year":"1993","unstructured":"Sisson JC, Ackermann RJ, Meyer MA. Uptake of 18-fluoro-2deoxy-d-glucose by thyroid cancer: implications for diagnosis and therapy.J Clin Endocrinol Metab 1993; 77: 1090?1094.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR10","first-page":"780","volume":"2","author":"L Fridrich","year":"1994","unstructured":"Fridrich L, Messa C, Landoni C, et al. PET\/[F-18]FDG and I-131 scintigraphy in patients with thyroid carcinoma (ThC).Eur J Nucl Med 1994; 2: 780.","journal-title":"Eur J Nucl Med"},{"key":"CR11","unstructured":"Baqai FH, Conti PS, Singer PA, et al.18F-FDG-PET scanning ? a diagnostic tool for detection of recurrent and metastatic differentiated thyroid cancers [abstract]. 68th annual meeting of the American Thyroid Association, Chicago 1994, p 9."},{"key":"CR12","first-page":"152","volume":"34","author":"D Platz","year":"1995","unstructured":"Platz D, L\u00fcbeck M, Beyer W, et al. Einsatz der [18F]-deoxy-glucose-PET (FDG-PET) in der Nachsorge von Patienten mit differenziertem und medull\u00e4rem Schilddr\u00fcsencarcinom.Nucl Med 1995; 34: 152.","journal-title":"Nucl Med"},{"key":"CR13","first-page":"197","volume":"36","author":"E Easton","year":"1995","unstructured":"Easton E, Coates D, McKusick A, et al. Concurrent FDG F-18 thyorid PET imaging in 1-131 therapy patients.J Nucl Med 1995;36:197.","journal-title":"J Nucl Med"},{"key":"CR14","first-page":"127","volume":"34","author":"U Feine","year":"1995","unstructured":"Feine U, Lietzenmayer R, Hanke JP, W\u00f6hrle H, M\u00fcller-Schauenburg W.18FDG whole-body PET in differentiated thyroid carcinoma.Nucl Med 1995; 34: 127?134.","journal-title":"Nucl Med"},{"key":"CR15","series-title":"Illustrierter Leitfaden zur TNM\/pTNM-Klassifikation maligner Tumoren\/International Union Against Cancer\/Union Internationale Contre le Cancer (UICC)","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/978-3-662-10569-6","volume-title":"TNM-Atlas","author":"B Spiessl","year":"1993","unstructured":"Spiessl B, Beahrs OH, Hermanek P, et al. TNM-Atlas.Illustrierter Leitfaden zur TNM\/pTNM-Klassifikation maligner Tumoren\/International Union Against Cancer\/Union Internationale Contre le Cancer (UICC). Berlin Heidelberg New York: Springer; 1993: 58."},{"key":"CR16","first-page":"20","volume":"22","author":"HJ Biersack","year":"1983","unstructured":"Biersack HJ, Helpap B, Koch U, et al. Should treatment of highly differentiated thyroid carcinoma be conservative?Nucl Med 1983; 22: 20?23.","journal-title":"Nucl Med"},{"key":"CR17","first-page":"266","volume":"27","author":"F Gr\u00fcnwald","year":"1988","unstructured":"Gr\u00fcnwald F, Ruhlmann J, Ammari B, et al. Experience with a high-dose concept of differentiated metastatic thyroid cancer therapy. Nucl Med 1988; 27: 266?271.","journal-title":"Nucl Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF00956719","volume":"18","author":"HJ Biersack","year":"1991","unstructured":"Biersack HJ, Hotze A. The clinician and the thyroid. Eur J Nucl Med 1991; 18: 761?778.","journal-title":"Eur J Nucl Med"},{"key":"CR19","first-page":"383","volume":"32","author":"AL Hotze","year":"1991","unstructured":"Hotze AL, Briele B, Gr\u00fcnwald F, et al. Determination of serum human thyroglobulin (hTg) with a new IRMA system in patients with differentiated thyroid carcinoma.Radiol Diagn 1991; 32: 383?386.","journal-title":"Radiol Diagn"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2265.1991.tb00937.x","volume":"35","author":"EG Black","year":"1991","unstructured":"Black EG, Sheppard MC. Serum thyroglobulin measurement in thyroid cancer: evaluation of ?false? positive results.Clin Endocrinol 1991; 35: 519?520.","journal-title":"Clin Endocrinol"},{"key":"CR21","first-page":"98","volume":"79","author":"M Ozata","year":"1994","unstructured":"Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, Degroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer.J Clin Endocrinol Metab 1994; 79: 98?105.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR22","first-page":"257","volume":"35","author":"E Lubin","year":"1994","unstructured":"Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.J Nucl Med 1994; 35: 257?262.","journal-title":"J Nucl Med"},{"key":"CR23","first-page":"1647","volume":"35","author":"PJ Lewis","year":"1994","unstructured":"Lewis PJ, Salama A. Uptake of fluorine-l8-fluorodeoxyglucose in sarcoidosis.J Nucl Med 1994; 35: 1647?1649.","journal-title":"J Nucl Med"},{"key":"CR24","first-page":"613","volume":"36","author":"WJG Oyen","year":"1995","unstructured":"Oyen WJG, Mudde AH, van den Brock WJM, Corstens FHM. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.J Nucl Med 1995; 36: 613?615.","journal-title":"J Nucl Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00256624","volume":"13","author":"H Joensuu","year":"1988","unstructured":"Joensuu H, Ahonen A, Klemi PJ.18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.Eur J Nucl Med 1988; 13: 502?506.","journal-title":"Eur J Nucl Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/thy.1993.3.195","volume":"3","author":"LP Adler","year":"1993","unstructured":"Adler LP, Bloom AD, Positron emission tomography of thyroid masses.Thyroid 1993; 3: 195?200.","journal-title":"Thyroid"},{"key":"CR27","first-page":"1843","volume":"36","author":"GC Scott","year":"1995","unstructured":"Scott GC, Meier DA, Dickinson CZ. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.J Nucl Med 1995, 36: 1843?1845.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00837630.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00837630\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00837630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T13:22:58Z","timestamp":1556284978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00837630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,3]]}},"alternative-id":["BF00837630"],"URL":"https:\/\/doi.org\/10.1007\/bf00837630","relation":{},"ISSN":["0340-6997","1619-7089"],"issn-type":[{"value":"0340-6997","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}